Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Announces Publication of Clinical Autonomic Research Supplement Focusing On Neurogenic Orthostatic Hypotension

CHARLOTTE, N.C., April 22, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that Clinical Autonomic Research, the official peer reviewed journal of the...
April 08, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Gains Global Rights to I-3D Portfolio Targeting Autoimmune Disease and Transplant Rejection

CHARLOTTE, N.C., April 8, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has acquired full global rights to the I-3D portfolio of orally active,...
March 25, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Significant Efficacy of CH-4051 in Reduction of Collagen-Induced Arthritis in Animal Model

CHARLOTTE, N.C., March 25, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced positive results from a preclinical study to investigate the use of CH-4051, the...
March 20, 2008 09:26 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the BioCentury Future Leaders in the Biotech Industry Conference

CHARLOTTE, N.C., March 20, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Future Leaders in the Biotech Industry Conference hosted by...
March 11, 2008 16:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Fourth Quarter and Full Year 2007 Results

CHARLOTTE, N.C., March 11, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today presented a quarterly update on the Company's development progress, reported financial...
March 04, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2007 Financial Results

CHARLOTTE, N.C., March 4, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release fourth quarter and full year results for the period ended...
February 19, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Receives Special Protocol Assessment for Pivotal Phase 3 Study of Droxidopa in Neurogenic Orthostatic Hypotension

CHARLOTTE, N.C., Feb. 19, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a...
February 08, 2008 07:30 ET | Source: Chelsea Therapeutics

Two New Independent Directors Join Chelsea Therapeutics

CHARLOTTE, N.C., Feb. 8, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that Roger Stoll, Ph.D., and Norman Hardman, Ph.D., have been appointed to the...
February 07, 2008 07:25 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension

CHARLOTTE, N.C., Feb. 7, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it has initiated patient dosing in study 302, the first of two pivotal Phase III...
February 04, 2008 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at 10th Annual BIO CEO & Investor Conference

CHARLOTTE, N.C., Feb. 4, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 10th Annual BIO CEO & Investor Conference at 11:45 AM EST on...